WARSAW, Ind., Oct. 1, 2014 /PRNewswire/ -- Zimmer
Holdings, Inc. (NYSE and SIX: ZMH) announced today that it has
acquired the business of Cambridge,
Massachusetts-based ETEX Holdings, Incorporated. The
financial terms of the transaction were not disclosed. The
acquisition enhances Zimmer's Biologics portfolio of differentiated
treatments through the addition of ETEX's
Beta-bsm™ (Injectable), CarriGen®,
EquivaBone® (including DBM), and
Gamma-bsm™ (Putty) bone void filler products.
"Since 1989, ETEX has been focused on Dosuk Lee's vision of
providing clinical solutions that advance the orthopaedic standard
of care. His breakthrough technology in biomimetic calcium
phosphate, which mimics the chemical and structural features of
human bone, promotes natural bone regeneration that positively
impacts patients' lives," said Stephen R.
La Neve, ETEX President and Chief Executive Officer.
"Zimmer's long history, dedication and focus in the orthopaedic
market is a perfect complement to our technology and dramatically
expands our ability to reach a broader array of clinicians."
"Zimmer is committed to developing the most comprehensive range
of biologic therapies for patients suffering from musculoskeletal
joint disease, from early intervention solutions like
Gel-One®* Cross-linked Hyaluronate
and joint preservation solutions like Zimmer Knee
Creations™ Subchondroplasty® Procedure,
along with Zimmer's
Chondrofix® Osteochondral Allograft and
Denovo® NT Natural Tissue Graft personalized
cartilage solutions. ETEX's innovative bone substitute
material products add more depth to a growing portfolio of
solutions for the early stages of joint disease," said Joseph
A. Cucolo, President, Zimmer Americas.
*Gel-One is a registered trademark of Seikagaku Corporation.
About the Company
Founded in 1927 and headquartered in
Warsaw, Indiana, Zimmer designs,
develops, manufactures and markets orthopaedic reconstructive,
spinal and trauma devices, dental implants, and related surgical
products. Zimmer has operations in more than 25 countries
around the world and sells products in more than 100
countries. Zimmer's 2013 sales were approximately
$4.6 billion. The Company is
supported by the efforts of more than 9,000 employees
worldwide. More information about Zimmer is available at
www.zimmer.com.
About ETEX Holdings, Inc.
Established in 1989, ETEX Holdings, Inc. develops, manufactures and
commercializes calcium phosphate-based biomaterials for improved
orthopedic clinical outcomes. A leader in bioresorbable bone
substitute materials, ETEX focuses on expanding applications
through combinations with cells, biologics, or therapeutic agents
delivered in minimally invasive and easy to use systems. For
more information, visit www.etexcorp.com.
Zimmer Safe Harbor Statement
This press release
contains forward-looking statements within the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995
based on current expectations, estimates, forecasts and projections
about the orthopaedics industry, management's beliefs and
assumptions made by management. Forward-looking statements
may be identified by the use of forward-looking terms such as
"may," "will," "expects," "believes," "anticipates," "plans,"
"estimates," "projects," "assumes," "guides," "targets,"
"forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These
statements are not guarantees of future performance and involve
risks, uncertainties and assumptions that could cause actual
outcomes and results to differ materially. For a list and
description of such risks and uncertainties, see our periodic
reports filed with the U.S. Securities and Exchange
Commission. We disclaim any intention or obligation to update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise, except as may be set
forth in our periodic reports. Readers of this document are
cautioned not to place undue reliance on these forward-looking
statements, since, while we believe the assumptions on which the
forward-looking statements are based are reasonable, there can be
no assurance that these forward-looking statements will prove to be
accurate. This cautionary statement is applicable to all
forward-looking statements contained in this document.
Logo -
http://photos.prnewswire.com/prnh/20131216/MM33947LOGO
SOURCE Zimmer Holdings, Inc.